Multicenter phase II study of neoadjuvant lapatinib and trastuzumab with hormonal therapy and without chemotherapy in patients with human epidermal growth factor receptor 2-overexpressing breast cancer: TBCRC 006 (Q36810717)
Jump to navigation
Jump to search
scientific article published on 8 April 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Multicenter phase II study of neoadjuvant lapatinib and trastuzumab with hormonal therapy and without chemotherapy in patients with human epidermal growth factor receptor 2-overexpressing breast cancer: TBCRC 006 |
scientific article published on 8 April 2013 |
Statements
1 reference
Multicenter phase II study of neoadjuvant lapatinib and trastuzumab with hormonal therapy and without chemotherapy in patients with human epidermal growth factor receptor 2-overexpressing breast cancer: TBCRC 006 (English)
1 reference
Rachel Schiff
1 reference
Matthew P Goetz
1 reference
Mothaffar F Rimawi
1 reference
Ingrid A Mayer
1 reference
Andres Forero
1 reference
Rita Nanda
1 reference
Angel A Rodriguez
1 reference
Anne C Pavlick
1 reference
Tao Wang
1 reference
Susan G Hilsenbeck
1 reference
Carolina Gutierrez
1 reference
C Kent Osborne
1 reference
Jenny C Chang
1 reference
1 reference
Identifiers
1 reference